Skip to content
AwardedSVKGoodsFramework agreement€468,088

Lieky ovplyvňujúce koaguláciu a hemodynamiku

Published
Published 13 April 2026
Deadline
Closed 13 May 2026

Overview

The National Institute of Cardiac and Vascular Diseases has awarded a contract to UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť for the supply of medicines affecting coagulation and hemodynamics, divided into three separate lots for a 36-month supply period. The award was completed on 13 July 2026 for a total value of 695,551.60 EUR.

Key details

Country
SVK
Status
Awarded
Category
Goods
Estimated value
€468,088
Procedure
Open
Contract type
Framework agreement
SME suitable
Yes
Published
13 April 2026
Deadline
Closed
Classification (CPV)
Antithrombotic agentsAntihaemorrhagicsPituitary, hypothalamic hormones and analogues

Award outcome

Awarded value
€695,552
Award date
13 July 2026
Contract period
— → 27 June 2029
Winner
  • UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    16 July 2026

  2. Contract Notice

    13 April 2026

Contracting authority

  • Národný ústav srdcových a cievnych chorôb, a.s.

    Procuring entity

    Bratislava, SVK

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Lieky ovplyvňujúce koaguláciu a hemodynamiku — won by UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť — Skim